According to AlphaMoat, in 2026-08 Aureka Biotechnologies (aurekabio.com) received 12,497 monthly visits (+110.5% MoM) — ranked #9,107 of 17,407 AI websites with traffic data, and #1,332 of 3,173 in Industry Services; its largest market is United States (92.7% of visits).
What is Aureka Biotechnologies
Aureka Biotechnologies builds AuraIDE, an antibody drug-discovery platform driven by high-throughput proprietary data and generative AI, combining digital biology with AI to accelerate high-value protein drug discovery through rapid generate-test-learn-optimize iteration.
- 01The platform supports function-first high-throughput antibody design across cardiovascular-metabolic and inflammatory disease areas
- 02it pairs an internal differentiated antibody pipeline and uses data-driven AI to shorten traditional discovery cycles
Offers platform partnerships and drug-discovery services to pharmaceutical and biotechnology companies, with specific deal structures subject to commercial discussion.
12-Month Traffic Trend
Visits by Country · Top 5
Popular in Industry Services
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.